BiosimilarsintheUnitedStates2023–2027COMPETITION,SAVINGS,ANDSUSTAINABILITYJANUARY2023ThefirstbiosimilarapprovedundertheabbreviatedpathwayestablishedbytheBiologicsPriceCompetitionandInnovationActlaunchedintheU.S.in2015,whilesomenon-originalbiologicshavebeenapprovedthroughotherpathwaysbothbeforeandsince.Despiteslowerinitialuptake,biosimilarlaunchesinthelastthreeyearshavegenerallybeenmoresuccessfulthanearlier,raisingimportantquestionsforupcomingbiosimilars,wheresavingsandpatientaccesscouldincreasesubstantially.Inthisreport,thecurrentstateofthebiologicsmarketintheUnitedStatesandshareofthemarketfacingbiosimilarcompetitionareassessed.Factorsimpactingbiosimilar...
发表评论取消回复